Bio-Techne Ownership | Who Owns Bio-Techne?


Bio-Techne Ownership Summary


Bio-Techne is owned by 55.31% institutional investors, 1.45% insiders, and 43.25% retail investors. Vanguard group is the largest institutional shareholder, holding 11.73% of TECH shares. US Small-Cap Growth II Equity Comp is the top mutual fund, with 4.16% of its assets in Bio-Techne shares.

TECH Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockBio-Techne55.31%1.45%43.25%
SectorHealthcare Stocks 57.00%9.26%33.74%
IndustryBiotech Stocks 68.69%8.88%22.43%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Vanguard group18.59M11.73%$1.34B
Blackrock14.99M9.53%$1.07B
Blackrock funding, inc. /de14.04M8.85%$1.01B
Price t rowe associates inc /md/10.65M6.72%$767.43M
State street6.30M4.01%$451.46M
Ameriprise financial4.70M2.97%$338.76M
Morgan stanley4.41M2.80%$316.03M
Bamco inc /ny/4.14M2.61%$297.99M
Geode capital management4.00M2.52%$287.49M
Invesco3.82M2.41%$275.19M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Broadcrest asset management100.00K10.79%$7.20M
Montanaro asset management332.50K4.94%$23.95M
Jackson square partners413.18K3.10%$29.76M
Brown capital management1.85M3.08%$133.09M
Df dent3.20M2.92%$230.60M
American capital management1.06M2.85%$76.63M
Summit creek advisors250.49K2.46%$17.95M
Ownership capital b.v.906.81K2.40%$65.32M
Sandhill capital partners420.21K2.37%$30.27M
Pembroke management260.04K2.34%$18.73M

Top Buyers

HolderShares% AssetsChange
Norges bank1.91M0.02%1.91M
Price t rowe associates inc /md/10.65M0.09%1.23M
Raymond james financial617.51K0.02%617.51K
Select equity group2.34M0.67%495.40K
Ubs group727.80K0.01%451.46K

Top Sellers

HolderShares% AssetsChange
Blackrock14.99M0.02%-2.76M
Point72 asset management---1.12M
Alyeska investment group---911.53K
Eagle asset management308.84K0.12%-702.23K
Millennium management655.79K0.02%-616.15K

New Positions

HolderShares% AssetsChangeValue
Norges bank1.91M0.02%1.91M$137.30M
Raymond james financial617.51K0.02%617.51K$44.48M
Hollow brook wealth management102.94K2.28%102.94K$7.41M
Arrowstreet capital, limited partnership54.70K0.00%54.70K$3.94M
Balyasny asset management47.07K0.01%47.07K$3.39M

Sold Out

HolderChange
Tfo-tdc-1.00
Scarborough advisors-2.00
Colonial trust advisors-3.00
Riggs asset managment-4.00
Claris advisors, llc / mo /-5.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 2024375-33.86%87,681,274-42.64%550.59%184-25.51%124-41.23%
Sep 30, 2024563-2.09%152,780,329-2.07%960.98%246-11.83%2090.48%
Jun 30, 20245681.25%155,969,245-0.67%991.00%2761.47%20611.96%
Mar 31, 20245614.28%157,019,3151.00%991.02%272-7.48%18411.52%
Dec 31, 20235380.75%155,459,8623.52%981.09%29427.27%165-22.90%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
US Small-Cap Growth II Equity Comp6.62M4.16%780.85K
T. Rowe Price New Horizons6.62M4.16%-
Vanguard Total Stock Mkt Idx Inv4.97M3.13%4.83K
Vanguard Institutional 500 Index Trust4.30M2.71%66.60K
Vanguard Small Cap Index4.05M2.55%44.69K
Eaton Vance Atlanta Capital SMID-Cap I2.44M1.55%-
Champlain Mid Cap Fund, LLC2.34M1.48%-60.51K
Vanguard Small Cap Growth Index Inv2.29M1.44%91.44K
Neuberger Berman Genesis Inv2.20M1.39%-
Baron Small Cap Growth Strategy2.20M1.38%-135.00K

Recent Insider Transactions


DateNameRoleActivityValue
Feb 14, 2025Herr Amy E.-Sell$122.69K
Jan 27, 2025Kelderman Kim Chief Executive OfficerSell$905.53K
Jan 27, 2025Kelderman Kim Chief Executive OfficerSell$129.48K
Aug 08, 2024BAUMGARTNER ROBERT V-Sell$1.15M
May 14, 2024HIGGINS JOHN L-Sell$335.38K

Insider Transactions Trends


DateBuySell
2025 Q1-2
2024 Q4--
2024 Q3-1
2024 Q2-1
2024 Q1-1

TECH Ownership FAQ


Who Owns Bio-Techne?

Bio-Techne shareholders are primarily institutional investors at 55.31%, followed by 1.45% insiders and 43.24% retail investors. The average institutional ownership in Bio-Techne's industry, Biotech Stocks , is 68.69%, which Bio-Techne falls below.

Who owns the most shares of Bio-Techne?

Bio-Techne’s largest shareholders are Vanguard group (18.59M shares, 11.73%), Blackrock (14.99M shares, 9.53%), and Blackrock funding, inc. /de (14.04M shares, 8.85%). Together, they hold 30.11% of Bio-Techne’s total shares outstanding.

Does Blackrock own Bio-Techne?

Yes, BlackRock owns 9.53% of Bio-Techne, totaling 14.99M shares as of Jun 2024. This represents 0.02% of BlackRock's total assets, with a market value of 1.07B$. In the last quarter, BlackRock decreased its holdings by -2.758M shares, a -15.54% change.

Who is Bio-Techne’s biggest shareholder by percentage of total assets invested?

Broadcrest asset management is Bio-Techne’s biggest shareholder by percentage of total assets invested, with 10.79% of its assets in 100K Bio-Techne shares, valued at 7.2M$.

Who is the top mutual fund holder of Bio-Techne shares?

US Small-Cap Growth II Equity Comp is the top mutual fund holder of Bio-Techne shares, with 4.16% of its total shares outstanding invested in 6.62M Bio-Techne shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools